BCI-215
BCI-215 is a small molecule that induces selective cytotoxicity in cancer cells. Its mechanism involves a non-redox activation of the MAPK signaling pathway. This compound is a useful research tool for investigating targeted cancer therapies in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1245792-67-9
Product Name Alternative
Phosphatase, specificity, Inhibitor, inhibit, MAPK, BCI 215, BCI215, BCI-215, DUSP-MKP, dual
Field of Research
Metabolism Research
Purity
≥95% (May vary between batches)
Solubility
DMSO:3.97 mg/mL (10.02 mM)
Smiles
Brc1ccc2C (=O) \C (=C\c3ccccc3) C (NC3CCCCC3) c2c1
Molecular Formula
C22H22BrNO
Molecular Weight
396.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1005028-01 0.05 mg (E-Coli)
Recombinant Pseudomonas stutzeri Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details MBS1005028-02 0.05 mg (Yeast)
Recombinant Pseudomonas stutzeri Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details MBS1005028-03 0.2 mg (E-Coli)
Recombinant Pseudomonas stutzeri Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details MBS1005028-04 0.05 mg (Baculovirus)
Recombinant Pseudomonas stutzeri Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details